Pfm Health Sciences, LP
Investment Portfolio & 13F Holdings Analysis
About
PFM Health Sciences, LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 65 holdings worth $1.4 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.
AI_NATIVE detailed information: This accession holds the following tickers:[ "AXSM", "ASND", "CNTA", "ARGX", "NEO", "HUM", null, "ABBV", "ALNY", "CRBU", "MGX", "SWTX", "GPCR", "SNDX", "KROS", "AMLX", "AZN", "OSCR", "ISRG", "INBX", null, "PMVP", "SGMT", null, "TSBX", "IQV", "IOVA", null, "ICLR", "UNH", "TMO", "PRAX", "SLNO", "ACLX", "QURE", "INDV.L", "BOLD", null, "VRTX", "EW", "SRPT", "PEN", "THC", "CMPS", "ERAS", "IOBT", "HCA", "VERV", "WAT", "HOWL", "XENE", "BHVN", "MOH", "UHS", "MCK", "BDX", "BPMC", "BBIO", "CAPR", "CELC", "CNC", "CVS", "DHR", "ELV", "LLY" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 65
- Total Value
- 1374770860
- Accession Number
- 0001085146-25-003307
- Form Type
- 13F-HR
- Manager Name
- Pfm-Health-Sciences-Lp
Data Enrichment
92% identified60 identified5 unidentified
Holdings
65 positions • $1.4B total value
Manager:
Search and click to pin securities to the top
Page 1 of 4
81369Y209
Shares:429.7K
Value:$62.7M
% of Portfolio:4.6% ($62.7M/$1.4B)
Shares:127.0K
Value:$61.6M
% of Portfolio:4.5% ($61.6M/$1.4B)
Shares:155.5K
Value:$29.2M
% of Portfolio:2.1% ($29.2M/$1.4B)
04351PAD3
Shares:—
Value:$27.3M
% of Portfolio:2.0% ($27.3M/$1.4B)
Shares:87.1K
Value:$23.5M
% of Portfolio:1.7% ($23.5M/$1.4B)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
---|---|---|---|---|---|---|
ELI LILLY & Co(LLYcusip532457108) | 273.8K | All Managers (Combined) | $226.1M | 16.4% ($226.1M/$1.4B) | ||
AbbVie Inc.(ABBVcusip00287Y109) | 331.7K | QoQ 0.00% (+0) | All Managers (Combined) | $69.5M | 5.1% ($69.5M/$1.4B) | |
491.3K | QoQ 0.00% (+0) | All Managers (Combined) | $66.1M | 4.8% ($66.1M/$1.4B) | ||
MCKESSON CORP(MCKcusip58155Q103) | 97.5K | All Managers (Combined) | $65.6M | 4.8% ($65.6M/$1.4B) | ||
556.5K | All Managers (Combined) | $64.9M | 4.7% ($64.9M/$1.4B) | |||
(cusip81369Y209)✕ | 429.7K | YoY NEW(+429.7K) | All Managers (Combined) | $62.7M | 4.6% ($62.7M/$1.4B) | YoY NEW(+$62.7M) |
127.0K | QoQ 0.00% (+0) | All Managers (Combined) | $61.6M | 4.5% ($61.6M/$1.4B) | ||
93.1K | QoQ 0.00% (-0) | All Managers (Combined) | $46.1M | 3.4% ($46.1M/$1.4B) | ||
Penumbra Inc(PENcusip70975L107) | 166.3K | QoQ 0.00% (+0) | All Managers (Combined) | $44.5M | 3.2% ($44.5M/$1.4B) | |
595.2K | YoY NEW(+595.2K) | All Managers (Combined) | $42.5M | 3.1% ($42.5M/$1.4B) | YoY NEW(+$42.5M) | |
69.0K | All Managers (Combined) | $40.8M | 3.0% ($40.8M/$1.4B) | |||
88.2K | QoQ NEW(+88.2K) | All Managers (Combined) | $38.4M | 2.8% ($38.4M/$1.4B) | QoQ NEW(+$38.4M) | |
908.1K | YoY NEW(+908.1K) | All Managers (Combined) | $31.4M | 2.3% ($31.4M/$1.4B) | YoY NEW(+$31.4M) | |
155.5K | All Managers (Combined) | $29.2M | 2.1% ($29.2M/$1.4B) | |||
186.9K | YoY NEW(+186.9K) | All Managers (Combined) | $29.1M | 2.1% ($29.1M/$1.4B) | YoY NEW(+$29.1M) | |
380.0K | All Managers (Combined) | $27.5M | 2.0% ($27.5M/$1.4B) | |||
(cusip04351PAD3)✕ | — | All Managers (Combined) | $27.3M | 2.0% ($27.3M/$1.4B) | ||
77.5K | All Managers (Combined) | $26.8M | 1.9% ($26.8M/$1.4B) | |||
87.1K | QoQ NEW(+87.1K) YoY NEW(+87.1K) | All Managers (Combined) | $23.5M | 1.7% ($23.5M/$1.4B) | QoQ NEW(+$23.5M) YoY NEW(+$23.5M) | |
70.1K | All Managers (Combined) | $23.1M | 1.7% ($23.1M/$1.4B) |